Enter glutathione, universally recognized in the medical community as the "master intracellular antioxidant." While healthy bodies naturally synthesize enough of this vital compound to neutralize daily metabolic waste, the immense inflammatory burden of complex chronic illnesses can overwhelm these built-in systems
The benefits of GLP-1 medications go beyond glucose control and supporting weight loss they can also reduce the risk of serious complications like heart disease, kidney disease, and fatty liver disease
The function of IGFBPs with respect to IGF-I signaling depends on the relative molar ratio between IGFBPs and IGF-I, but IGFBPs are primarily considered to work as inhibitors for IGF-I, as is true for IGFBP-2, which has been shown to block IGF-I binding to its receptor
Individuals with hypercholesterolemia exhibited approximately 42% lower plasma ALC levels than those of the general population (Figure 1A)
Furthermore, animal models of DKD show a reduced abundance of beneficial bacteria such as Bifidobacterium and Prevotella , along with increased abundance of Escherichia-Shigella [127, 129]